Skip To Content

News & Events: Uncategorized

Posts

  • July 16 2019

    Tonix Pharmaceuticals Holding Corp. announced the closing of its public offering in the amount of $5,400,000.  EG&S acted as counsel to Aegis Capital Corp, the sole book runner for the offering.

  • February 08 2019

    Douglas S. Ellenoff, a member of the Firm, was invited by Deal Flow Events to open the SPAC Conference 2019 with the keynote address.  EGS served as the premier sponsor.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”